Since POLG1 mutations usually manifest as multisystem disease, we should be informed about the entire phenotype of the two siblings. Particularly we would like to know which organs other than the brain were affected, which pattern of organ involvement was observed during the course, and if there was phenotypic heterogeneity between the two siblings. POLG1 mutations may additionally manifest in the ears as hypoacusis, in the skeletal muscle, peripheral nerves, eyes, gastrointestinal tract, endocrine organs, and the skin (Finsterer and Scorza 2018) .
Did each of the consanguineous parents carry the mutation? Were other first-degree family members clinically affected? What about the grandparents of these siblings? Were blood test ever carried out in sibling-1? Was parathormone normal? Was there pituitary insufficiency? Was there growth hormone deficiency? Were the parents phenotypically striking?
Which was the cause of death in sibling-1 after delivery? It is mentioned that there were intrauterine seizures (InbarFeigenberg et al. 2018) . Did sibling-1 also present with seizures during the short period of his postnatal life? Did sibling-1 die from intractable seizures, central respiratory insufficiency, or from cardiac or pulmonary compromise? Was fetal ECG and echocardiography normal? Was an EEG recorded?
In summary, it is not unusual that patients carrying POLG1 mutations manifest with cerebellar atrophy. Cerebellar atrophy occurs also frequently in MIDs due to mutations in genes other than POLG1. The genetic status of the parents should be provided and the entire clinical presentation of the two siblings should be reported in detail.
